Ritlecitinib-impurities | Pharmaffiliates

Ritlecitinib

Ritlecitinib is a small molecule, being developed by Pfizer, for the oral treatment of ulcerative colitis, alopecia areata, vitiligo, and Crohn's disease. Reference standards of Ritlecitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Ritlecitinib - API Standards 
    [catalogue_number] => PA 18 1470000
    [category_ids] => ,76,75,78,70,82,87,
    [chemical_name] => 
    [weight] => 285.35
    [form] => C15H19N5O
    [cas] => 1792180-81-4
    [pslug] => 1792180-81-4-ritlecitinib-api-pa181470000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 1470000

Ritlecitinib - API Standards


  • Catalogue No.:PA 18 1470000

  • CAS :

    1792180-81-4

  • Molecular Formula : C15H19N5O

  • Molecular Weight : 285.35